JAAD Case Reports (Oct 2023)

Use of TYK2 inhibitor to relieve reactive granulomatous dermatitis due to myelodysplastic syndrome

  • Christina Huang, BS,
  • Adar Berghoff, MD,
  • Jack L. Arbiser, MD, PhD

Journal volume & issue
Vol. 40
pp. 41 – 44

Abstract

Read online

No abstracts available.

Keywords